PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Public Health and Pediatrics, University of Turin, Turin, Italy.\', \'Medical Affairs, Servier Italia SpA, Rome, Italy.\', \'Department of Internal Medicine, Hospital Fatebenefratelli-AFaR, Rome, Italy.\', \'Department of Pharmaceutical Sciences, University of Milan, Milan, Italy.\', \'Janssen-Cilag SpA, Milan, Italy.\', \'High Research, Milan, Italy.\', \'Department of Internal Medicine, Madonna del Buonconsiglio Fatebenefratelli Hospital, Naples, Italy.\', \'Roche SpA, Switzerland.\', \'Oncology Department, Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.\', \'Biostatistics and Clinical Trials Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola (FC), Italy.\', \'Bayer SpA, Milan, Italy.\', \'Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.\', \'Clinical Research Department, \'Centro Studi\' FADOI, Milan, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1177/0300891620977916
?:hasPublicationType
?:journal
  • Tumori
is ?:pmid of
?:pmid
?:pmid
  • 33297885
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.396
?:rankingScore_hIndex
  • 48
?:title
  • Lessons learned from COVID-19 for clinical research operations in Italy: what have we learned and what can we apply in the future?
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33297885>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33297885>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all